Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ligand posts 4Q profit as charge comes off books
Yahoo/AP
Tuesday, February 9, 2010 - 6:26pm
tags:
Ligand, earnings
Ista forecasts first annual profit in 2010
Yahoo/AP
Tuesday, February 9, 2010 - 6:23pm
tags:
Isis Pharmaceuticals, guidance
FDA Agreements Should Be Public
Forbes
Tuesday, February 9, 2010 - 6:14pm
tags:
FDA
Botox Curbs Emotions, Study Says ... and Now Allergan Is Marketing It to Men
BNET Pharma
Tuesday, February 9, 2010 - 6:12pm
tags:
Allergan, Botox
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tuesday, February 9, 2010 - 10:58am
tags:
FDA, Cadence Pharmaceuticals, Acorda Therapeutics, Auxilium, Gilead Sciences, Shire, Amylin, Cell Therapeutics, Dendreon, InterMune, Amgen, Human Genome, NicOx, Vivus, Arena Pharmaceuticals, Orexigen
Sequenom licenses rights to potential test
Yahoo/AP
Tuesday, February 9, 2010 - 10:56am
tags:
Sequenom, macular degeneration
Adoption of Cerus' Technology Makes Its Valuation Look Ridiculous
Seeking Alpha
Tuesday, February 9, 2010 - 10:53am
tags:
Cerus, INTERCEPT
Fujifilm aims for Japanese generics market
Fierce Pharma
Tuesday, February 9, 2010 - 10:50am
tags:
Fujifilm, generics, Japanese
Cell Therapeutics’ Last Hope for Survival, Dashed
Minyanville
Tuesday, February 9, 2010 - 10:48am
tags:
Cell Therapeutics, pixantrone, lymphoma
[[video]Orexigen CEO Talks Obesity
Yahoo/CNBC
Tuesday, February 9, 2010 - 9:51am
tags:
Pharma CEOs, obesity, Orexigen, Michael Narachi
Paxil Linked To Deaths In Breast Cancer Patients
Pharmalot
Tuesday, February 9, 2010 - 9:50am
tags:
Paxil, tamoxifen, breast cancer
BMS's "Information Security Department" Has Spyware for Employee Laptops
BNET Pharma
Tuesday, February 9, 2010 - 9:49am
tags:
sales reps, Bristol-Myers Squibb
Amgen Tops Novartis at Reducing Fractures in Prostate Patients
Bloomberg
Tuesday, February 9, 2010 - 9:39am
tags:
Amgen, Novartis, denosumab, prostate cancer, Zometa
Biogen Fourth-Quarter Profit Rises on Tysabri Sales
Bloomberg
Tuesday, February 9, 2010 - 9:37am
tags:
Biogen Idec, earnings, Tysabri
Dynavax starts hepatitis B trial
Bizjournals.com
Tuesday, February 9, 2010 - 9:36am
tags:
clinical trials, hepatitis B, Dynavax, Heplisav, vaccines
A Win For Crestor, AstraZeneca
Forbes
Tuesday, February 9, 2010 - 9:35am
tags:
Crestor, FDA, heart disease, AstraZeneca
Alkermes Retains Neutral Rec
Yahoo/Zacks.com
Tuesday, February 9, 2010 - 9:34am
tags:
Alkermes, Amylin, JNJ
Eli Lilly CEO’s 2009 Compensation Totaled $16.4 Million
WSJ Online
Tuesday, February 9, 2010 - 9:33am
tags:
Eli Lilly, Pharma CEOs, John Lechleiter
[video] Is Biotech Back?
Yahoo/CNBC
Monday, February 8, 2010 - 12:39pm
tags:
biotech
FDA Raises Concerns About Cell Therapeutics' Cancer Drug
TheStreet.com
Monday, February 8, 2010 - 12:38pm
tags:
Cell Therapeutics, FDA, pixantrone, lymphoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.